Immunic Inc (IMUX) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $0.95
• Market Cap: $109.51M
• EPS: $-0.80
• 52-Week High: $1.35
• 52-Week Low: $0.51

Market Sentiment

Immunic Inc currently has a Neutral sentiment score of 0.04.

About Immunic Inc

Immunic, Inc. (IMUX) is a clinical-stage biopharmaceutical company based in New York, specializing in the development of innovative oral immunology therapies for chronic autoimmune and inflammatory diseases. With a focus on addressing significant unmet medical needs, Immunic leverages its proprietary drug development platform to advance a robust pipeline of candidates currently in clinical trials. The company's commitment to enhancing patient outcomes positions it strategically within the bio...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Immunic Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does IMUX pay dividends?

Immunic Inc (IMUX) does not currently pay a regular dividend.

What is IMUX's market cap?

Immunic Inc (IMUX) has a market capitalization of $109.51M with a current stock price of $0.95.